immunity News and Research

RSS

Nanovaccine boosts immunity in mice with gut microbiome-mediated metabolic syndrome

A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.

29 Mar 2019

Researchers discover 'taste bud cells' in mice lungs after severe bout of flu

Most people who weather an infection with influenza fully recover after a week or two. But for some, a severe case of the flu can actually reshape the architecture of their lungs and forever compromise their respiratory function.

29 Mar 2019

Dogs could be source of novel human influenza strains, 10-year study suggests

Results from a 10-year study suggest two strains of influenza that could mix and form a dangerous new strain of influenza spread by dogs.

28 Mar 2019

LNC Therapeutics announces grant of Cornell University patent relating to christensenella bacteria

LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery, announced today the grant of the Cornell University (Ithaca, New-York, USA) patent relating to christensenella bacteria.

26 Mar 2019

Anti-TB drugs can increase susceptibility to Mtb reinfection

Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.

22 Mar 2019

Anti-vaxxer Italian leader down with chickenpox

In a twist of fate, an Italian politician who was lobbying against mandatory vaccination laws, has come down with chickenpox and is now hospitalized.

21 Mar 2019

Scientists identify generation of key immune response in mice on introducing solid food

Microbes colonize all body surfaces and help to balance the immune system. In newborn infants, gut microbiota is first conditioned by breast milk components.

20 Mar 2019

Study illuminates how hot spots of genetic variation evolved in the human genome

What makes one person different from one another, and how did these differences evolve? A study by University at Buffalo biologists is illuminating one aspect of this complicated question. The research examines hot spots of genetic variation within the human genome, examining the sections of our DNA that are most likely to differ significantly from one person to another.

20 Mar 2019

Cholesterol lowering drug can also help treat cancer-associated cachexia

Brazilian researchers have discovered that a drug regularly prescribed to control cholesterol can also be used to treat cachexia, or wasting syndrome, a condition characterized by rapid weight loss and muscle atrophy associated with extreme physical weakness.

19 Mar 2019

New analysis compares scenarios to find the best time to get a flu shot

When flu season peaks after mid-winter, tens of thousands of influenza cases and hundreds of deaths can likely be avoided if older adults wait until October to get their flu immunization, a University of Pittsburgh School of Medicine analysis reveals in the April issue of the American Journal of Preventive Medicine.

15 Mar 2019

Preclinical data shows combination immunotherapy could suppress tumor growth in the liver

Even as overall cancer incidence and mortality decrease in the United States, the number of people diagnosed with liver cancer is on the rise.

14 Mar 2019

Association found between gene variant and lung disease in the form of systemic vasculitis

University of Tsukuba-led team reveals the association between a gene variant and a lung disease in the form of systemic vasculitis particularly prevalent in the Japanese, potentially providing a target for future therapies.

13 Mar 2019

Killer flu pandemic is inevitable and world is not prepared, says WHO

The World Health Organisation has said that the world is not prepared for a global flu pandemic and that resources are inadequate.

12 Mar 2019

New data describes way to reliably quantify a person's 'immune age'

New data, published in Nature Medicine, from scientists at the Technion, Stanford and CytoReason describes for the first time ever a way to reliably quantify a person's "immune age".

12 Mar 2019

Virginia Tech professor uses mathematical modeling simulations to assess vaccine efficacy

The recent measles outbreaks across the country emphasize the importance of vaccinations.

11 Mar 2019

Study reveals how the microbiota controls activity of immune cells

A host protein called Serum Amyloid A (Saa) is a major factor mediating the effects of the microbiota on the function of immune cells called neutrophils, according to a study published March 7 in the open-access journal PLOS Pathogens by John Rawls of Duke University School of Medicine, and colleagues.

8 Mar 2019